State Street’s Genprex GNPX Stock Holding History

State Street’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4	Closed	-$39.7K	–	4381
2023 Q4	$39.7K	Hold	4	–	–	﹤0.01%	4240
2023 Q3	$68.1K	Hold	4	–	–	﹤0.01%	4205
2023 Q2	$164K	Hold	4	–	–	﹤0.01%	4061
2023 Q1	$157K	Buy	4 +1	+33%	+$56.4K	﹤0.01%	4159
2022 Q4	$188K	Hold	3	–	–	﹤0.01%	4130
2022 Q3	$183K	Hold	3	–	–	﹤0.01%	4185
2022 Q2	$180K	Hold	3	–	–	﹤0.01%	4254
2022 Q1	$294K	Buy	3 +1	+50%	+$97.5K	﹤0.01%	4245
2021 Q4	$144K	Hold	2	–	–	﹤0.01%	4475
2021 Q3	$294K	Hold	2	–	–	﹤0.01%	4208
2021 Q2	$338K	Sell	2 -11	-85%	-$1.8M	﹤0.01%	4007
2021 Q1	$2.39M	Buy	13 +3	+30%	+$659K	﹤0.01%	3364
2020 Q4	$1.91M	Hold	10	–	–	﹤0.01%	3396
2020 Q3	$1.44M	Hold	10	–	–	﹤0.01%	3325
2020 Q2	$1.36M	Buy	+10	New	+$1.22M	﹤0.01%	3315

Other funds holding GNPX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

State Street's GNPX Position: Q1 2024 in Review

State Street sold out of Genprex (GNPX) in Q1 2024, closing a stake of 4 shares — an estimated $39.7K sold.

State Street first reported a position in GNPX in Q2 2020 and held it in 15 quarters. The position peaked at $2.39M in Q1 2021. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

State Street reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
State Street sold 4 Genprex shares in Q1 2024, an estimated $39.7K.
State Street first reported a position in Genprex in Q2 2020 and held it in 15 quarters.
State Street's Genprex position peaked at $2.39M in Q1 2021.
8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.